Our focus is on developing new medicines to make a meaningful difference to patients’ lives - and the UK is right at the heart of our efforts to do that.
For more than 40 years, our UK operations have been fundamental to the innovation and success of our scientific research and medicine development.
We have eight sites across the UK and around 6,700 employees that contribute to our ongoing achievements. Our sites cover a range of functions including research and development (Alderley Park and Macclesfield), manufacturing and supply (Macclesfield and Avlon), sales and marketing (Luton), as well as an environmental research facility in Brixham and our head office in London.
MedImmune, the company we acquired in 2007, also accounts for two of our eight sites in the UK (Cambridge and Speke), making up our biologics capability.